StockNews.AI
HIMS
StockNews.AI
33 days

The Gross Law Firm Reminds Hims & Hers Health, Inc. Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of August 25, 2025 - HIMS

1. Hims faces class action for misleading statements regarding Wegovy® sales. 2. Allegations claim patient safety risks and potential end of collaboration with Novo Nordisk. 3. Shareholders can register for potential recovery by August 25, 2025. 4. Gross Law Firm emphasizes investor protection against deceit and fraud. 5. Company's positive statements are deemed misleading, raising investor concerns.

5m saved
Insight
Article

FAQ

Why Bearish?

The allegations could significantly undermine investor confidence and company reputation, similar impacts seen in past class actions.

How important is it?

The article highlights serious allegations that could damage Hims' brand and investor trust, directly influencing its stock performance.

Why Short Term?

Class action news typically leads to immediate stock volatility as investors react to litigation risks.

Related Companies

NEW YORK, July 17, 2025 /PRNewswire/

The Gross Law Firm issues the following notice to shareholders of Hims & Hers Health, Inc. (NYSE: HIMS).

Shareholders who purchased shares of HIMS during the class period listed are encouraged to contact the firm regarding possible lead plaintiff appointment. Appointment as lead plaintiff is not required to partake in any recovery.

CONTACT US HERE:

https://securitiesclasslaw.com/securities/hims-hers-health-inc-loss-submission-form/?id=156860&from=4

CLASS PERIOD:

April 29, 2025 to June 23, 2025

ALLEGATIONS:

The complaint alleges that during the class period, Defendants issued materially false and/or misleading statements and/or failed to disclose that: (1) Hims was engaged in the "deceptive promotion and selling of illegitimate, knockoff versions of Wegovy® that put patient safety at risk;" (2) as a result, there was a substantial risk that the Company's collaboration with Novo Nordisk would be terminated; and (3) as a result of the foregoing, defendants' positive statements about the Company's business, operations, and prospects were materially misleading and/or lacked a reasonable basis.

DEADLINE:

August 25, 2025 Shareholders should not delay in registering for this class action. Register your information here: https://securitiesclasslaw.com/securities/hims-hers-health-inc-loss-submission-form/?id=156860&from=4

NEXT STEPS FOR SHAREHOLDERS:

Once you register as a shareholder who purchased shares of HIMS during the timeframe listed above, you will be enrolled in a portfolio monitoring software to provide you with status updates throughout the lifecycle of the case. The deadline to seek to be a lead plaintiff is August 25, 2025. There is no cost or obligation to you to participate in this case.

WHY GROSS LAW FIRM?

The Gross Law Firm is a nationally recognized class action law firm, and our mission is to protect the rights of all investors who have suffered as a result of deceit, fraud, and illegal business practices. The Gross Law Firm is committed to ensuring that companies adhere to responsible business practices and engage in good corporate citizenship. The firm seeks recovery on behalf of investors who incurred losses when false and/or misleading statements or the omission of material information by a company lead to artificial inflation of the company's stock. Attorney advertising. Prior results do not guarantee similar outcomes.

CONTACT:

The Gross Law Firm
15 West 38th Street, 12th floor
New York, NY, 10018
Email: info@grosslawfirm.com
Phone: (646) 453-8903

SOURCE The Gross Law Firm

Related News